Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage

BACKGROUND: Metastatic castration-resistant prostate cancer (CRPC) is the leading cause of death among men diagnosed with prostate cancer. Piperlongumine (PL) is a novel potential anticancer agent that has been demonstrated to exhibit anticancer efficacy against prostate cancer cells. However, the e...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Complement Med Ther
Egile Nagusiak: Zhang, Ding-fang, Yang, Zhi-chun, Chen, Jian-qiang, Jin, Xiang-xiang, Qiu, Yin-da, Chen, Xiao-jing, Shi, Hong-yi, Liu, Zhi-guo, Wang, Min-shan, Liang, Guang, Zheng, Xiao-hui
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2021
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8261967/
https://ncbi.nlm.nih.gov/pubmed/34229670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-021-03369-0
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak